BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26402312)

  • 1. DOG1 expression in giant-cell-containing bone tumours.
    Cleven AH; Briaire-de Bruijn I; Szuhai K; Bovée JV
    Histopathology; 2016 May; 68(6):942-5. PubMed ID: 26402312
    [No Abstract]   [Full Text] [Related]  

  • 2. Discovered on gastrointestinal stromal tumour 1 (DOG1): a useful immunohistochemical marker for diagnosing chondroblastoma.
    Akpalo H; Lange C; Zustin J
    Histopathology; 2012 Jun; 60(7):1099-106. PubMed ID: 22335248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondroblastoma: An Update.
    Chen W; DiFrancesco LM
    Arch Pathol Lab Med; 2017 Jun; 141(6):867-871. PubMed ID: 28557595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of 36 cases of chondroblastomas: A single institutional experience.
    Rekhi B; Ghate S; Shah A; Ramadwar M; Gulia A
    Ann Diagn Pathol; 2020 Feb; 44():151440. PubMed ID: 31862519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovered on gastrointestinal stromal tumours 1 (DOG1) expression in non-gastrointestinal stromal tumour (non-GIST) neoplasms.
    Tang YL; Wong CF; Yap WM; Chuah KL
    Histopathology; 2014 Nov; 65(5):724-6. PubMed ID: 24713079
    [No Abstract]   [Full Text] [Related]  

  • 6. Histone H3K36M mutation and trimethylation patterns in chondroblastoma.
    Lu C; Ramirez D; Hwang S; Jungbluth A; Frosina D; Ntiamoah P; Healey J; Zhu G; Chen W; Klein M; Hameed M
    Histopathology; 2019 Jan; 74(2):291-299. PubMed ID: 30098026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma.
    Amary MF; Berisha F; Mozela R; Gibbons R; Guttridge A; O'Donnell P; Baumhoer D; Tirabosco R; Flanagan AM
    Histopathology; 2016 Jul; 69(1):121-7. PubMed ID: 26844533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combined immunohistochemical and histochemical approach on the differential diagnosis of giant cell epiphyseal neoplasms.
    Karabela-Bouropoulou V; Markaki S; Prevedorou D; Vidali N
    Pathol Res Pract; 1989 Feb; 184(2):184-7. PubMed ID: 2710683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratin-, calponin-, and p63-positive chondroblastoma with extensive soft tissue involvement and vascular invasion: a potential diagnostic dilemma.
    Ho YH; Cheng MH; Yap WM; Chuah KL
    Ann Diagn Pathol; 2011 Feb; 15(1):58-63. PubMed ID: 20952302
    [No Abstract]   [Full Text] [Related]  

  • 10. DOG1 Expression in Low-Grade Fibromyxoid Sarcoma: A Study of 11 Cases, With Molecular Characterization.
    Thway K; Ng W; Benson C; Chapman J; Fisher C
    Int J Surg Pathol; 2015 Sep; 23(6):454-60. PubMed ID: 26135531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Use for DOG1 in Discriminating Breast Invasive Carcinoma from Noninvasive Breast Lesions.
    Cheng H; Yang S; Qu Z; Zhou S; Ruan Q
    Dis Markers; 2016; 2016():5628176. PubMed ID: 27041791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chondroblastoma with adamantinoma differentiation of the calcaneus.
    Liu D; Xiao P; Gao Z; Xue L; Wang L; Liu Y; Han A
    Pathology; 2011 Feb; 43(2):174-6. PubMed ID: 21233685
    [No Abstract]   [Full Text] [Related]  

  • 13. DOG1 (clone K9) is seldom expressed and not useful in the evaluation of pancreatic neoplasms.
    Hemminger J; Marsh WL; Iwenofu OH; Frankel WL
    Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):397-401. PubMed ID: 22495382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of successful detection of disseminated gastrointestinal stromal tumors by ascites smear cytology using cell block preparation with DOG1 immunostaining.
    Tajima S; Kawabe A; Nagasaka K; Oda K; Kawana K; Fukayama M
    Diagn Cytopathol; 2016 Feb; 44(2):137-40. PubMed ID: 26646159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas.
    Abd Raboh NM; Hakim SA
    Int J Clin Exp Pathol; 2015; 8(8):9214-22. PubMed ID: 26464669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RANK signalling in bone lesions with osteoclast-like giant cells.
    Won KY; Kalil RK; Kim YW; Park YK
    Pathology; 2011 Jun; 43(4):318-21. PubMed ID: 21532526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of DOG1 immunohistochemistry in dermatopathology.
    Goto K
    J Cutan Pathol; 2016 Nov; 43(11):974-983. PubMed ID: 27506854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and treatment of patellar chondroblastoma].
    Cheng Q; Huang W
    Zhongguo Gu Shang; 2013 Dec; 26(12):1059-62. PubMed ID: 24654528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
    Li Y; Liang Q; Wen YQ; Chen LL; Wang LT; Liu YL; Luo CQ; Liang HZ; Li MT; Li Z
    Cancer Genet Cytogenet; 2010 Apr; 198(2):97-106. PubMed ID: 20362224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of immunohistochemistry in the diagnosis of bone tumors and tumor-like lesions.
    Gao Z; Kahn LB
    Skeletal Radiol; 2005 Dec; 34(12):755-70. PubMed ID: 16189715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.